Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-01-12

Clinical Trial Update: Intensified vs. Standard Dose Therapy With Mycophenolate Sodium Plus Cyclosporin Microemulsion and Corticosteroid Combination in Patients With de Novo Renal Transplant Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing intensified versus standard-dose immunosuppressive therapy with mycophenolate sodium, cyclosporin microemulsion, and corticosteroids i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mycophenolate sodium (mycophenolate sodium)
  • PREDNISONE (Prednisone)
  • cyclosporine microemulsion (cyclosporine)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Renal Transplantation | Phase 3 | Status: COMPLETED | Results posted: 2011-01-12